← Back to Fund Radar
ONCO

Acciones Onconetix Inc

US68237Q2030 · ONCO (NCM)

0 value funds · 1 CNMV managers

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.

Value funds holding it
0

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →
Funds (CNMV universe)
1

0 → 1 (+1) · net presence change vs. previous period

Avg. weight
0.10%
Price
—
Sector
-
Industry
-

CNMV data · half-year closed 2025-12-31.

No ticker identified yet: no price or market data for this ISIN.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 1 Exits: 0 Increasing exposure: 0 Reducing exposure: 0
+ ABANTE QUANT VALUE, F.I.

Enters the position at 0.10% weight.

Objective ratios

Not enough financial data on Yahoo Finance to calculate ratios for this company.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.